Literature DB >> 27008494

Predictive value of clinical history compared with urodynamic study in 1,179 women.

Jorge Milhem Haddad1, Helga Elisa Marquesini Gonzales Monaco2, Clarice Kwon2, Wanderley Marques Bernardo3, Homero Gustavo de Campos Guidi2, Edmund Chada Baracat4.   

Abstract

OBJECTIVE: to determine the positive predictive value of clinical history in comparison with urodynamic study for the diagnosis of urinary incontinence.
METHODS: retrospective analysis comparing clinical history and urodynamic evaluation of 1,179 women with urinary incontinence. The urodynamic study was considered the gold standard, whereas the clinical history was the new test to be assessed. This was established after analyzing each method as the gold standard through the difference between their positive predictive values.
RESULTS: the positive predictive values of clinical history compared with urodynamic study for diagnosis of stress urinary incontinence, overactive bladder and mixed urinary incontinence were, respectively, 37% (95% CI 31-44), 40% (95% CI 33-47) and 16% (95% CI 14-19).
CONCLUSION: we concluded that the positive predictive value of clinical history was low compared with urodynamic study for urinary incontinence diagnosis. The positive predictive value was low even among women with pure stress urinary incontinence.

Entities:  

Mesh:

Year:  2016        PMID: 27008494     DOI: 10.1590/1806-9282.62.01.54

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

1.  Can conventional urodynamic variables help to predict the necessity of overactive bladder symptomatic therapy in women after transobturator tape surgery?

Authors:  Zane Pilsetniece; Egils Vjaters
Journal:  Cent European J Urol       Date:  2020-09-08

2.  Comparison of Solifenacin and Bilateral Apical Fixation in the Treatment of Mixed and Urgency Urinary Incontinence in Women: URGE 1 Study, A Randomized Clinical Trial.

Authors:  Sebastian Ludwig; Ingrid Becker; Peter Mallmann; Wolfram Jäger
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.